Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
08/2005
08/11/2005US20050176137 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
08/11/2005US20050176130 Functional mutations in respiratory syncytial virus
08/11/2005US20050175991 Using fluid comprising bacteria lysing virus bacteria as tool in cleaning fruits and vegatables
08/11/2005US20050175711 Shark cartilage extracts and use thereof for immunomodulation
08/11/2005US20050175644 Preparation for oxidation-sensitive compounds and method for making same
08/11/2005US20050175636 Containing stabilized neurotoxin as analgesic and skin penetration enhancing agent; inflammation and/or pain reduction
08/11/2005US20050175598 Methods of use of probiotic bifidobacteria for companion animals
08/11/2005US20050175597 For easy administration and storage stability
08/11/2005US20050175596 Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells
08/11/2005US20050175595 Method for reinstalling control system for antigenic homeostasis of mammalian organisms (effect of Kukharchuk-Radchenko-Sirman)
08/11/2005US20050175592 Storage stability; use of bulking agents, cryoprotectants and lyoprotectants imparts desired properties that allow both lyophilized and liquid adenovirus formulations to be stored at 4 degrees C. for up to 6 months and retain an infectivity between 60-100% of the starting infectivity
08/11/2005US20050175589 Anti-neoplastic viral agents
08/11/2005DE202005007671U1 Beeswax compress, useful for treating pain or coughing or for immune stimulation, comprises fatty or ethereal oils
08/11/2005CA2554932A1 Solvent extraction of lipids such as essential fatty acids
08/11/2005CA2553671A1 Method for the separation of phospholipids from phospholipid-containing materials
08/11/2005CA2552392A1 Apicomplex vaccine strains of a family of sarcocystidae
08/10/2005EP1561817A2 Modified CEA and uses thereof
08/10/2005EP1561468A1 Pharmaceutical antidiabetic composition
08/10/2005EP1560935A2 Self-containing lactobacillus strain
08/10/2005EP1560591A2 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto
08/10/2005EP1560491A2 Bacteriophage having modified holin and uses thereof
08/10/2005EP1292317B1 Hypotensive and hypertensive properties of renomedullar extracts
08/10/2005EP1210092A4 Calcium-containing structures and methods of making and using the same
08/10/2005EP1169441B8 Pharmaceutical compositions for the treatment of heart failure
08/10/2005EP1096941B1 Bone marrow cells as a source of neurons for brain and spinal cord repair
08/10/2005EP1051207B1 Radiopaque implantable collagenous biomaterial device
08/10/2005CN1653184A Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
08/10/2005CN1653183A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
08/10/2005CN1653182A Recombinant fowlpox virus
08/10/2005CN1653179A Cartilage regeneration using chondrocyte and TGF-beta
08/10/2005CN1653176A Compositions and methods for generating an immune response
08/10/2005CN1653080A Lymphatic and blood endothelial cell genes
08/10/2005CN1652839A System and method for treating cardiac arrhythmias with fibroblast cells
08/10/2005CN1652831A Electrocardiographic aspects of CHF treatment
08/10/2005CN1652813A Pharmaceutical compositions comprising mannose binding lectin
08/10/2005CN1652804A Method for extended storage of blood and blood components
08/10/2005CN1652785A Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
08/10/2005CN1652770A Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
08/10/2005CN1652698A Method and dietary composition for improving lipid digestibility
08/10/2005CN1652697A Method and dietary composition for improving fat digestibility
08/10/2005CN1652696A Method of improving absorption of vitamin E by a pet animal
08/10/2005CN1651919A CD154 blockade monoclone antibody use for inhibiting rejection of insulin producing tissue transplantation
08/10/2005CN1651573A New Aike 30 Virus and its use
08/10/2005CN1651458A Antigenic proteins of shrimp white spot syndrome virus and uses thereof
08/10/2005CN1651074A Use of neurotoxin therapy for treatment of urologic and related disorders
08/10/2005CN1650893A Health care product for treating intestine duct disease, preparation and use method thereof
08/10/2005CN1650892A Water soluble medicament for anti inflammation, repressing bacteria, eliminating pes off smell and treating asjike, and its application
08/10/2005CN1650891A Medicinal composition posssessing synergistic action
08/10/2005CN1650890A Child metho kahuangmin effervescent granules and its making method
08/10/2005CN1214042C Production process for intravenous immune serum globulin and resultant product
08/10/2005CN1213774C Technology for preparation of biological dressing material
08/10/2005CN1213768C Method of treating endotoxemia
08/10/2005CN1213764C Medicated liquor for treating chronic osteonosus and preparing process thereof
08/10/2005CN1213763C Oral liquor for treating diabetes and preparation method thereof
08/09/2005US6927061 Capable of differentiating into ovarian surface epithelial and granulosa cells
08/09/2005US6927060 Generation of preferential progenitor cells; obtain cells, separate progenitor cells, progagate and recover preferential progenitor cells
08/09/2005US6926898 Albumin fusion proteins
08/09/2005US6926893 Multi-stage cascade boosting vaccine
08/09/2005US6926891 administering to a mammal at risk of diarrhea a formulation including a therapeutically effective amount of a Bifidobacterium capable of preventing colonization of bacteria causing diarrhea
08/09/2005US6926888 producer cell ( encapsulated in a matrix which containing alginates) containing a plasmid that includes a nucleic acid sequence that encodes endostatin, angiostatin, thrombospondin, or prolactin
08/04/2005WO2005071082A1 Antisense oligonucleotide having anticancerous activity
08/04/2005WO2005071066A1 Methods and compositions for preparing pancreatic insulin secreting cells
08/04/2005WO2005071063A1 Methods of making and using skin-derived stem cells
08/04/2005WO2005070964A1 Method of isolating monocytes
08/04/2005WO2005070459A1 Method of continuing expression of vector repeatedly administered
08/04/2005WO2005070458A1 Improved iga production method
08/04/2005WO2005070453A1 Monoparamunity inducers based on attenuated rabbit myxoma viruses
08/04/2005WO2005070439A1 Implant comprising a human muscle tissue matrix
08/04/2005WO2005070415A1 Adjuvant compositions
08/04/2005WO2005070090A2 Regulatory t cells suppress autoimmunity
08/04/2005WO2005070011A2 Improved modalities for the treatment of degenerative diseases of the retina
08/04/2005WO2005069941A2 An artificial bait based on a peptide attractant found in horseshoe crab eggs
08/04/2005WO2005069758A2 Frequency assisted transdermal agent delivery method and system
08/04/2005WO2005058889A3 Biological active blood serum obtained by electrostimulation
08/04/2005WO2005039319A3 Synbiotic composition for infants
08/04/2005WO2004092360A3 The severe acute respiratory syndrome coronavirus
08/04/2005US20050172347 Using nuclear transformation to generate animal embryo; animal models; uniformity of meat product; animal management
08/04/2005US20050170506 Using nuclear transplantation as tool in generating pluripotent cells; tissue engineering; regenerative medicine
08/04/2005US20050170500 Methods for identifying risk of melanoma and treatments thereof
08/04/2005US20050170348 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
08/04/2005US20050170327 Isolating thrombocytes from whole blood via agglutinating and sedimenting erthrocytes; regenerative medicine; tisssue engineering
08/04/2005US20050170010 Pharmaceutical Antidiabetic Composition
08/04/2005US20050170009 Traditional chinese pharmaceutical formulation for treatment of paradentosis, process for preparation and use thereof
08/04/2005US20050170008 Pollen manufacturing method
08/04/2005US20050170007 Ude of a mare's milk concentrate dried on a highly-dispersed, biologically inert matrix
08/04/2005US20050169944 Administering ozone to reduce hypoxia; enhancing drug or radio therapy
08/04/2005US20050169937 Attacking immune tolerant species; having at least one consensus amino acid sequence
08/04/2005US20050169904 biodrug fusion protein comprising active mitochondrial protein or peptide, a mitochondrial membrane-permeant peptide and linking to a mitochondrial targeting sequence; targeting sequence is cleaved within the mitochondrial matrix, and not cleaved within the cellular cytoplasm; mitochondrial disorders
08/04/2005US20050169902 Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
08/04/2005US20050169901 controlling cytokine levels by administering extract or secreted products from microorganism; biosynthesis; atheroma, degenerative vascular disease or cardiovascular disease associated with inflammation of the coronary arteries; hypotensive agents, antilipemic agents, anticholesterol agents
08/04/2005US20050169898 Fusion of dendritic cells and antigen presenting cells; immunotherapy for stimulating an immune system; hybride cells; genetic engineering
08/04/2005US20050169897 Engraftable neural progenitor and stem cells for brain tumor therapy
08/04/2005US20050169896 Isolating stromal cells, administering to the central nervous system of a human patient; traumatic brain injury, spinal cord injury, neurodegeneration, Parkinson's disease
08/04/2005US20050169890 Recombinant vector; overexpresses an adenovirus death protein (ADP), is replication-restricted to neoplastic cells expressing telomerase
08/04/2005CA2555370A1 Improved modalities for the treatment of degenerative diseases of the retina
08/04/2005CA2554732A1 Methods of making and using skin-derived stem cells
08/04/2005CA2554587A1 Medicinal soap
08/04/2005CA2553986A1 Adjuvant compositions
08/04/2005CA2553854A1 Immunomodulatory alkaloids
08/04/2005CA2552891A1 Regulatory t cells suppress autoimmunity
1 ... 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 ... 1259